Teladoc Health Inc. kicked off the trading day on 10/09/19 with a price increase of 3.38%, equivalent to $2.22 relative change for the day. Taking a more long-term approach, TDOC had a 52-week range of $42.08 to $75.93. At the time of this article’s publishing, this stock is trading at $67.81 after starting the trading session at $66.00. At the time of writing, this stock’s 50-day Moving Average stands at $64.50, while the 200-day Moving Average of this stock is currently $61.53.
Currently, this company’s share volume is sitting at $1204478, but has maintained average daily volume of $1.33M. This stock has generated an average Year to Date volume of $1.37 million, alongside an average 20-day volume of $1.57 million. This publicly-traded company’s shares outstanding now amounts to $71.72 million, simultaneously with a float of $71.23 million. The organization now has a market capitalization sitting at $4.86 billion.
Teladoc Health Inc.(TDOC) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. Teladoc Health Inc.’s current insider ownership accounts for 1.10%. According to the most recent latest insider trade that took place on Oct 01 this organization’s Chief Medical Officer exercised an option 1,350 at the rate of 36.60, making the entire transaction hit 49,408 in total value, affecting insider ownership by 5,730. Preceding that transaction, on Oct 01 Company’s Chief Medical Officer sold 1,350 at a price of 67.79, making the whole transaction’s value amount to 91,517. This particular insider is now the holder of 4,380 in total.
All together, they are the legal holders of 71.72M shares. If we focus on the top 3 stockholders for this publicly-traded organization, The Vanguard Group, Inc. owns 6,125,486 shares, with BlackRock Fund Advisors in 2nd place owning 4,504,591 shares and JPMorgan Investment Management, Inc. in third place with total ownership of 4,246,794 shares.
Teladoc Health Inc. (TDOC) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported -$0.41 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at -$0.41) by $0.
This company achieved a net margin of -21.85 while generating a return on equity of -11.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
Teladoc Health Inc.’s EPS increase for this current 12-month fiscal period is 30.30%, and is forecasted to reach -1.18 in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 20.00% through the next 5 years, which can be compared against the 28.80% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
Now turning our attention to the current performance indicators for Teladoc Health Inc., this organization’s Quick Ratio in the last reported quarter now stands at 7.60. The company has managed to achieve an average true range (ATR) of 3.09. Alongside those, its Beta score is 1.39.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.87 for this organization. Similarly, its price to free cash flow for trailing twelve months is now 631.61. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 4.85, whereas its price to cash per share for the last quarter landed at 6.59.
In the same vein, TDOC’s Diluted EPS (Earnings per Share) trailing twelve months was posted at -1.53, a figure that is expected to reach -0.40 in the next reported quarter, and analysts expect it will be -1.18 at the market close of one year from today’s date.